Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
@mingwei, cause IVF centers are specialised and less price sensitive, with low incremental cost per cycle and strong pricing power from reputation, so margins can stay high
QoQ drop slightly due to lower inpatient volume after HSOP ended, but long-term outlook still healthy as private healthcare demand remains steady and the group continues expanding capacity
Market starting to notice this undervalued healthcare stock. Profit margin already around 20–30%, and this is not even factoring in the contribution from upcoming centres as the expansion continues.